OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.14
+0.28 (5.65%)
Jan 15, 2025, 9:40 AM EST - Market open
OptimizeRx Employees
As of December 31, 2023, OptimizeRx had 136 total employees, including 135 full-time and 1 part-time employees. The number of employees increased by 26 or 23.64% compared to the previous year.
Employees
136
Change (1Y)
26
Growth (1Y)
23.64%
Revenue / Employee
$648,379
Profits / Employee
-$177,749
Market Cap
94.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
OPRX News
- 23 days ago - OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO - GlobeNewsWire
- 2 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 4 months ago - OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - GlobeNewsWire
- 4 months ago - OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - GlobeNewsWire
- 5 months ago - OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - GlobeNewsWire